NAYA - Prakiraan volume dodolan NAYA Biosciences Inc.

NAYA Biosciences Inc - logo grafis emiten NAYA

The target sales volume of NAYA Biosciences (NAYA) demonstrates scaling potential driven by unique antibodies with high intellectual value, while the value of 0.01 aligns with the current metric. Development currently relies on external funding for early-stage testing due to the absence of a stable cash flow. The primary shield against acquisition by pharma behemoths remains the FLEX-NK platform patents, which are undergoing FDA review amidst a fierce scientific race.

NAYA Biosciences Corp - Volume dodolan sing dikarepake perusahaan NAYA (periode 04.07.2022 - 28.04.2025)

Rincian metrik keuangan lan pasar NAYA Bio (NAYA)

- nilai saham lan prakiraan konsensus rega:
Analisis umum perusahaan:NAYA Biosciences Inc
Sampel barang NAYA Biosciences Inc

This indicator aggregates total market forecasts for the issuer's future cash flows. By analyzing the company's future sales volume, investors assess the expected commercialization of NAYA Biosciences (NAYA) innovative antibodies for cancer treatment. This trend captures a shift in market expectations regarding the scalability of targeted therapy. Comparing current values with the historical trend allows for the timely detection of fundamental shifts, confirming the company's status as a promising scientific innovator.

Pesaing utama

Prakiraan volume dodolan ONC|HALO (Halozyme) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan RVMD (revmed.com)|Dodolan mangsa ngarep perusahaan Ascentage (AAPG)|CGON: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan UroGen Pharma Ltd.|BCAX: Prakiraan volume dodolan|PSNL - Dodolan mangsa ngarep perusahaan|ERAS (Erasca Oncology) - Prakiraan volume dodolan|Prakiraan volume dodolan Delcath Systems, Inc.|Prakiraan pendapatan perusahaan ymabs.com (YMAB)|Prakiraan pendapatan perusahaan AURA (Aura Biosciences, Inc.)|Candel Therapeutics - Volume dodolan mangsa ngarep perusahaan|Accuray Inc. (ARAY) - Volume dodolan sing dikarepake perusahaan|SELLAS Life Sciences Group, Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan ACTU (Actuate Therapeutics, Inc.)|Citius Oncology (CTOR) - Prakiraan pendapatan perusahaan|HURA - Dodolan mangsa ngarep perusahaan|TARA (Protara Therapeutics, Inc.) - Prakiraan volume dodolan|Prakiraan volume dodolan Fate Therapeutics Inc|Prakiraan volume dodolan WHWK|Prakiraan volume dodolan TScan Therapeutics Inc (TCRX)|Prakiraan pendapatan perusahaan championsoncology.com CSBR|XBIT - Volume dodolan mangsa ngarep perusahaan|CVM - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan OSTX (OS Therapies)|RADX: Prakiraan volume dodolan|Artiva Biotherapeutics Inc. - Pendapatan mangsa ngarep perusahaan|ANL (Adlai Nortye) - Prakiraan volume dodolan|Prakiraan volume dodolan verupharma.com|Volume dodolan mangsa ngarep perusahaan TPST (tempesttx.com)|Volume dodolan mangsa ngarep perusahaan Xilio Therapeutics Inc XLO|Prakiraan volume dodolan RENB (Enochian BioSciences)|Mural Bio - Prakiraan pendapatan perusahaan|KAPA - Prakiraan pendapatan perusahaan|OnKure Therapeutics (OKUR) - Volume dodolan mangsa ngarep perusahaan|GDTC: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Curis Corp (CRIS)|APLM (apollomicsinc.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Tharimmune Corp (THAR)|Prakiraan volume dodolan ADVB|GNPX - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan calidibio.com CLDI|SBFM - Volume dodolan mangsa ngarep perusahaan|XBIO - Prakiraan pendapatan perusahaan|SLRX: Prakiraan pendapatan perusahaan|Purple Biotech (PPBT) - Prakiraan pendapatan perusahaan|AON - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan BGNE|Prakiraan volume dodolan Checkpoint Therapeutics Inc.|Prakiraan volume dodolan ELEV|Volume dodolan mangsa ngarep perusahaan iCAD ICAD|Prakiraan volume dodolan IKNA (Ikena Oncology, Inc.)|Pendapatan mangsa ngarep perusahaan NTBL|Viracta Therapeutics, Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan MOR (MorphoSys Inc)|AAPGV: Prakiraan volume dodolan